Home|Journals|Articles by Year|Audio Abstracts
 

Review Article

RMJ. 2004; 29(2): 82-85


Treatment of chronic hepatitis B

Nasir Khokhar.




Abstract

Chronic hepatitis B is a serious clinical problem with worldwide distribution and has been well documented in Pakistan (1,2). Chronic hepatitis B is important in Asia pacific region because of its perinatal mode of transmission and high prevalence rate in early childhood where the carriage of hepatitis B virus (HBV) ranges from 0.1-20% (1-3). Chronic hepatitis B virus infection generally consist of an early replicative phase which is characterized by presence of hepatitis Be antigen (HBeAg) and high levels of serum HBV DNA and alanine aminotransferase (ALT) may be normal or abnormal (3). A late phase involves immune clearance of HBV and destruction of infected hepatocytes which may be manifested by more marked increases of aminotransferase levels and spontaneous, as well as treatment related, HBeAg sero-conversion is common (3).

Key words: CHB, HBV Lamivudine






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.